Cargando…
Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa
Junctional epidermolysis bullosa (JEB) patients experience skin and epithelial fragility due to a pathological deficiency in genes associated with epidermal adhesion. Disease severity ranges from post-natal lethality to localized skin involvement with persistent blistering followed by granulation ti...
Autores principales: | Tartaglia, Grace, Park, Pyung Hun, Alexander, Michael H., Nyström, Alexander, Rosenbloom, Joel, South, Andrew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216840/ https://www.ncbi.nlm.nih.gov/pubmed/37238610 http://dx.doi.org/10.3390/biom13050740 |
Ejemplares similares
-
Recent advances in understanding and managing epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2018) -
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023) -
Impaired Wound Healing, Fibrosis, and Cancer: The Paradigm of Recessive Dystrophic Epidermolysis Bullosa
por: Tartaglia, Grace, et al.
Publicado: (2021) -
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
por: Nyström, Alexander, et al.
Publicado: (2021) -
Epidermolysis bullosa aquisita with basal epidermal cytoplasmic antibodies.
por: Lee, C. W., et al.
Publicado: (1986)